Clinical Trial Update: A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase II study completed evaluating the pharmacokinetics, pharmacodynamics, and safety of single inhaled doses of Ensifentrine, glycopyrrolate, and their fixe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ensifentrine (ensifentrine)
• Ensifentrine-glycopyrrolate fixed-dose combination
• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED